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treatment of coronary artery disease (CAD). METHOD: In 
this prospective comparative cohort study in 30 hospitals in
Germany, patients with coronary artery disease (CAD) undergo-
ing PTCA were electively treated with drug-eluting stents (DES)
or bare-metal stents (BMS). Standardized questionnaires com-
pleted by patients and physicians at 3, 6, 12, and 18 months 
following PTCA documented major adverse coronary events
(MACE), including death, myocardial infarct, coronary bypass
surgery and reintervention as well as direct and indirect costs
related to CAD. Patient health-related and disease-speciﬁc
quality of life was documented with the SF-36 and MacNew
heart disease questionnaires. RESULTS: From April until August
2004, 237 patients were treated with DES (88% male, mean age
63 ± 10) und 241 patients with BMS (82% male, mean age 65
± 10). There were no signiﬁcant differences in socio-demographic
factors, cardiovascular risk factors and severity of CAD. After 6
months, 11.6% of the DES cohort and 26.7% of the BMS cohort
had suffered a MACE (p < 0.05). The quality of life (SF-36 phys-
ical and mental summary scores and MacNew global score) at 3
months was higher in the DES cohort than in the BMS cohort
but at 6 months, both groups were similar. Initial hospital costs
were signiﬁcantly higher for DES than for BMS (6290 ± 1800
vs. 3655 ± 541 €, p < 0.001). The 6-month follow-up costs of
DES tended to be less than those of BMS (4305 ± 6031 vs. 5873
± 6442 €, p = n.s.). CONCLUSIONS: In comparison to patients
following BMS implantation, patients 6 months following
implantation of a DES have considerably fewer clinically rele-
vant adverse events, while the quality of life at this time point
was similar in both cohorts. Initial hospital costs were signiﬁ-
cantly higher for DES than for BMS but 6-month follow-up costs
were less for DES.
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OBJECTIVES: To estimate the economic burden of coded post-
operative ileus (POI) among patients undergoing open laparo-
tomies in the US. METHODS: Using Premier’s PerspectiveTM
database, we identiﬁed 193,409 open laparotomy surgical
patients based on their primary discharge ICD-9 procedure code
during 2002. Coded POI was identiﬁed using ICD-9 diagnosis
codes 560.1 and 997.4. Risk factors for coded POI were ana-
lyzed by a logistic regression model. To assess the economic
burden of coded POI, multiple regression analyses were per-
formed predicting hospital length of stay and total hospital costs
while controlling for baseline variables. Estimates of incremen-
tal costs and length of hospital stay were projected to the
national level. RESULTS: Extended operating room time
increased the risk of coded POI by 20% for each one-hour
increase (OR, 1.20, 95% CI, 1.19–1.21). Mean operating room
time was 3.0 ± 1.7 hours for patients with coded POI versus 2.5
± 1.2 hours for patients without coded POI. Use of PCA opioids
increased the risk of coded POI by 39% (OR, 1.39, 95% CI,
1.34–1.44). Coded POI was associated with an additional 2.6
days (P < 0.01) in the hospital and $1763 (P < 0.01) in total 
hospital costs. For the US, the overall burden of coded POI for
open laparotomies was estimated to be an additional 370,000
days in the hospital and $253 million in total costs. CONCLU-
SIONS: POI is associated with a signiﬁcant economic impact.
Inpatients with coded POI have extended operating time and
increased use of PCA opioids. POI was also associated with
increased hospital stay and consequently, hospital costs. Since
POI may not be routinely coded in this database, the true eco-
nomic burden of POI may be underestimated. Strategies to
reduce the impact of POI should lead to economic savings to the
hospital system.
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OBJECTIVE: To determine the impact of age and gender on the
frequency and resource utilization among inpatients with a claim
for an elective surgery between October 2003 and September
2004 in the Premier Perspective Database. METHODS: All inpa-
tient and outpatient discharges with a claim for one of ﬁve elec-
tive surgeries between October 2003 and September 2004 were
retrieved. Procedures of interest were botox injections (botu-
linum toxin), liposuction (lipoplasty or lipectomy), nose reshap-
ing (rhinoplasty), breast augmentation (mammoplasty), and laser
treatment of leg veins (schlerotherapy or sclerosing). The rela-
tionship between each surgery and age, gender, length of stay,
and costs was examined, and the distinction between “elective”
and “necessary” surgeries is made where possible. RESULTS:
Overall, there were 2349 claims for botox injections (among
inpatients, 56% female; among outpatients, 62% female), 189
liposection procedures (over 91% females), 261 nose reshaping
procedures (55% male), 293 breast augmentations (over 96%
females), and 8,635 treatments of leg veins (among inpatients,
45% female; among outpatients, 50% female). With the excep-
tion of leg vein procedures, most were performed in hospital-
based outpatient clinics. Most botox procedures were performed
on females in outpatient clinic settings (n = 1177), and 9% were
performed on teens. Most liposection procedures were among
19–44 year-old females (57%) and middle-aged females (39%)
seen in outpatient clinics. In addition, most nose reshaping (more
common in males and teenagers received 10% of these proce-
dures) and breast augmentations occurred in the outpatient
setting (3% were among teens). Finally, most leg vein procedures
were among elderly inpatients, many of these non-elective surg-
eries. Additional results regarding the medications used, as well
as readmission, will be presented. CONCLUSION: Elective surg-
eries are common, and are captured in administrative hospital
data. Further research using data from specialty clinics should
be performed to better understand the magnitude and health
impacts associated with these procedures.
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OBJECTIVES: Numerous prescription products have become
available OTC in recent years and there are several reasons why
this number is likely to increase signiﬁcantly in the future. To
date, there have been simulation models, but no empirical assess-
ment of the impact of the Rx-to-OTC switch of loratadine. Pre-
